H.C. Wainwright initiated coverage of ASP Isotopes with a Buy rating and $3.25 price target. The analyst e expects ASP Isotopes to build upon its capability to produce enriched isotopes through its “proven and proprietary” Aerodynamic Separation Process technology. The firm says ASP’s technology provides a cost-effective means for isotope enrichment while also lowering the required initial capital barrier through a modular and scalable design.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ASPI:
- ASP Isotopes enters into MOU with U.S. SMR company to supply HALEU
- ASP Isotopes files to sell 10.15M shares of common stock for holders
- ASP Isotopes enters strategic relationship with PET Labs Pharmaceuticals
- ASP Isotopes Inc. Enters Strategic Relationship With PET Labs Pharmaceuticals for the Distribution of Medical Isotopes
- ASP Isotopes Announces Closing of $9.1 Million Private Placement of Common Stock